Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Drug-induced cholestasis (DIC) is poorly understood and its preclinical prediction is mainly limited to assessing the compound’s potential to inhibit the bile salt export pump (BSEP). Here, we evaluated two 3D spheroid models, one from primary human hepatocytes (PHH) and one from HepaRG cells, for the detection of compounds with cholestatic liability. By repeatedly co-exposing both models to a set of compounds with different mechanisms of hepatotoxicity and a non-toxic concentrated bile acid (BA) mixture for 8 days we observed a selective synergistic toxicity of compounds known to cause cholestatic or mixed cholestatic/hepatocellular toxicity and the BA mixture compared to exposure to the compounds alone, a phenomenon that was more pronounced after extending the exposure time to 14 days. In contrast, no such synergism was observed after both 8 and 14 days of exposure to the BA mixture for compounds that cause non-cholestatic hepatotoxicity. Mechanisms behind the toxicity of the cholestatic compound chlorpromazine were accurately detected in both spheroid models, including intracellular BA accumulation, inhibition of ABCB11 expression and disruption of the F-actin cytoskeleton. Furthermore, the observed synergistic toxicity of chlorpromazine and BA was associated with increased oxidative stress and modulation of death receptor signalling. Combined, our results demonstrate that the hepatic spheroid models presented here can be used to detect and study compounds with cholestatic liability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“3D spheroid models are reported to produce more accurate assessment of acute and possibly also chronic drug-induced hepatotoxicity than traditional 2D culture models (Messner et al. 2013) and to be capable of detecting compounds with cholestatic liability (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“However, a recent report suggested that bile-acid transport inhibition might be involved in part in bosentan-induced cytotoxicity in this model.”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
The cited source says what the claim attributes to it.
In the citing paper
“Addition of extracellular bile acids in the cell-culture media caused increased cytotoxicity of liver spheroid cultures relative to normal media treated spheroid cultures treated with bosentan over 14 day (Hendriks et al. 2016).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Hendriks et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Self-citationOutcome and prognostic markers in severe drug‐induced liver disease†
Björnsson, E., & Olsson, R. (2005) · Hepatology · doi:10.1002/hep.20800 · Cited by 524
Landry, J., Bernier, D., Ouellet, C., Goyette, R., & Marceau, N. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.914 · Cited by 520
Bile Acid Sulfation: A Pathway of Bile Acid Elimination and Detoxification
Alnouti, Y. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn268 · Cited by 390
Padda, M. S., Sanchez, M., Akhtar, A. J., & Boyer, J. L. (2011) · Hepatology · doi:10.1002/hep.24229 · Cited by 387
Swift*, B., Pfeifer*, N. D., & Brouwer, K. L. R. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903491881 · Cited by 365
Dawson, S., Stahl, S., Paul, N., Barber, J., & Kenna, J. G. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040758 · Cited by 343
Morgan, R. E., Trauner, M., van Staden, C. J., Lee, P. H., Ramachandran, B., Eschenberg, M., Afshari, C. A., Qualls, C. W., Lightfoot-Dunn, R., & Hamadeh, H. K. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq269 · Cited by 325
Multi-cell type human liver microtissues for hepatotoxicity testing
Messner, S., Agarkova, I., Moritz, W., & Kelm, J. M. (2013) · Archives of Toxicology · doi:10.1007/s00204-012-0968-2 · Cited by 319
Self-citation
Cited by
Items 101–156 of 156
Alshmmari, S. K., Fardous, R. S., Shinwari, Z., Cialla‐May, D., Popp, J., Ramadan, Q., & Zourob, M. M. (2024) · Biomicrofluidics · doi:10.1063/5.0210955 · Cited by 9
Abdellaoui-Soussi, F. E., Brusilovsky, M., Buck, E., Bacon, W. C., Dadgar, S., Fullerton, A. M., Durban, V. M., Barrile, R., Helmrath, M. A., Takebe, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202508584 · Cited by 16
Naito, Y., Yoshinouchi, Y., Sorayama, Y., Kohara, H., Kitano, S., Irie, S., & Matsusaki, M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.11.027 · Cited by 10
In vitro liver models for toxicological research
Fukunaga, I., & Takebe, T. (2025) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2025.101478 · Cited by 8
Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey
Bazydło‐Guzenda, K., Buda, P., Mach, M., Pieczykolan, J., Kozłowska, I., Janiszewski, M., Drzazga-Wilk, E., Dominowski, J., Ziółkowski, H., Wieczorek, M., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257477 · Cited by 8
Jeong, C. G., Negro, G. D., Getsios, S., & Ekert, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00005-0 · Cited by 13
Drees, A., Nassiri, V., Tabernilla, A., Serroyen, J., Gustin, E. M., Rodrigues, B. D. S., Moss, D. M., Smedt, A. D., Vinken, M., Goethem, F. V., et al. (2025) · Toxicology · doi:10.1016/j.tox.2025.154119 · Cited by 6
Negi, C. K., Sakolish, C., Tsai, H.-H. D., Nitsche, K. S., Gang, H., Bajaj, P., Ferguson, S., Stanko, J. P., Hewitt, P. G., Kukla, D. A., et al. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00554 · Cited by 7
Wu, Q., Duan, Z., Huang, L., & Li, Z. (2022) · Pharmaceutical Biology · doi:10.1080/13880209.2022.2110128 · Cited by 6
Influence of bile acids on the cytotoxicity of chemicals in cultivated human hepatocytes
Brecklinghaus, T., Albrecht, W., Kappenberg, F., Duda, J., Zhang, M., Gardner, I. B., Marchan, R., Ghallab, A., Turgunbayer, Ö. D., Rahnenführer, J., et al. (2022) · Toxicology in Vitro · doi:10.1016/j.tiv.2022.105344 · Cited by 7
Modelling the Sorafenib-resistant Liver Cancer Microenvironment by Using 3-D Spheroids
Sarıyar, E., & Karagonlar, Z. F. (2023) · Alternatives to Laboratory Animals · doi:10.1177/02611929231193421 · Cited by 8
Ingelman‐Sundberg, M., & Lauschke, V. M. (2024) · Drug Metabolism and Disposition · doi:10.1124/dmd.123.001302 · Cited by 7
Self-citationBorgström, A., Filippi, B. G. H., Hewitt, P. G., Wolf, A., & Gebauer, M. (2023) · Applied In Vitro Toxicology · doi:10.1089/aivt.2023.0004 · Cited by 4
Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes
Deferm, N., Richert, L., Brantegem, P. V., Vocht, T. D., Qi, B., de Witte, P. A. M., Bouillon, T. W., & Annaert, P. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9420-5_22 · Cited by 5
Cell-based approaches for the mechanistic understanding of drug-induced cholestatic liver injury
Timor-López, E., Tolosa, L., & Donato, M. T. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04016-0 · Cited by 5
Physiologically relevant microsystems to study viral infection in the human liver
McDuffie, D., Barr, D., Agarwal, A., & Thomas, E. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999366 · Cited by 4
Sakai, Y., Matsumura, M., Iwao, T., & Matsunaga, T. (2023) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-023-00805-y · Cited by 4
Nitsche, K. S., Sakolish, C., Carmichael, P. L., Hewitt, P. G., Bajaj, P., Ferguson, S., Lloyd, S. M., Wilson, S. S., Bouwmeester, H., & Rusyn, I. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04263-1 · Cited by 6
Li, Y., Sheng, H., Zhou, T., Xing, C., Kukasch, M., Shao, S., Youhanna, S. C., Vorrink, S. U., Liang, Y., Nies, A. T., et al. (2026) · Drug Metabolism and Disposition · doi:10.1016/j.dmd.2026.100346 · Cited by 3
Fardel, O., Moreau, A., Jouan, E., Denizot, C., Vée, M. L., & Parmentier, Y. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2453486 · Cited by 3
Engineering a three-dimensional liver steatosis model
Johnston, E. K., Zhou, F., Soto–Gutiérrez, A., Taner, C. B., Cook, K. E., Liu, Y., & Abbott, R. D. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167888 · Cited by 4
Bajaj, P., Brennan, R., Laurent, S., Sauzeat, S., Dufault, M. R., Richards, B., & Adkins, K. (2025) · Toxicological Sciences · doi:10.1093/toxsci/kfaf012 · Cited by 5
Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance
Hurrell, T., Naidoo, J., & Scholefield, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.864725 · Cited by 3
Hartauer, M., Ho, H. S. S., Wan, M., Murphy, W. A., Tiley, J. B., Fallon, J. K., Bishop, C. E., & Brouwer, K. L. R. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05996-z · Cited by 2
Scholten, G.-J., Grundmann, C. E., Nordling, Å., Coskun, C., Engelhardt, V., Sadhasivam, L., Einfalt, T., Ingelman‐Sundberg, M., & van Riet, S. (2026) · Clinical and Translational Science · doi:10.1111/cts.70536 · Cited by 3
Self-citationBeers, J. L., Harvey, S. L., Geffert, R. M., Rushing, B. R., McRitchie, S., Sumner, S., & Jackson, K. D. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106126 · Cited by 3
Dash, A., & Proctor, W. R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00006-2 · Cited by 4
Perspective on In Vitro Liver Toxicity Models
Witek, R. P., & Bonzo, J. A. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.29017.wit · Cited by 2
Timor-López, E., Tolosa, L., & Donato, M. T. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04324-z · Cited by 1
Keulen, J., Zhong, Y., Dangel, L., Youhanna, S. C., Shafagh, R. Z., Ryu, J., Gurau, D., Haag, M., Mürdter, T. E., Liang, Y., et al. (2026) · Advanced Science · doi:10.1002/advs.76256 · Cited by 1
Weitzberg, E., Ingelman‐Sundberg, M., Lundberg, J. O., Engberg, G., Schulte, G., & Lauschke, V. M. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.001433 · Cited by 1
Self-citationKarsten, R. E. H., Gier, K., de Meijer, V. E., Huibers, W. H. C., Permentier, H. P., Verpoorte, E. M. J., & Olinga, P. (2025) · Toxicology in Vitro · doi:10.1016/j.tiv.2025.106011 · Cited by 1
Han, W., & Duan, Z. (2019) · Toxin Reviews · doi:10.1080/15569543.2019.1639060 · Cited by 1
Evaluation of Human Liver Microtissues for Drug Screening on Schistosoma mansoni Schistosomula
Lombardo, F. C., Ravaynia, P. S., Modena, M. M., Hierlemann, A. R., & Keiser, J. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00614 · Cited by 1
Nautiyal, M., Bauch, C., Walker, P., Watkins, P. B., & Mosedale, M. (2020) · Applied In Vitro Toxicology · doi:10.1089/aivt.2020.0005 · Cited by 1
Mechanism‐Based Experimental Models for the Evaluation of BSEP Inhibition and DILI
Murphy, W. A., Saran, C., Honkakoski, P., & Brouwer, K. L. R. (2021) · Wiley eBooks · doi:10.1002/9781119171003.ch9 · Cited by 1
Ball, A. L., Kamalian, L., Jolly, C., & Chadwick, A. E. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch6
In vitro primary human hepatocyte 3D spheroid model for hepatotoxicity studies
Li, F., Parikh, S., Cao, L., Cooper, K., & Zuo, R. (2019) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.09.134
Sharma, A., & Shah, T. K. (2020) · International Journal of Chemical Studies · doi:10.22271/chemi.2020.v8.i2q.8913
Culture methods focusing on bile canalicular formation using primary human hepatocytes in short timePreprint
Sakai, Y., Matsumura, M., Iwao, T., & Matsunaga, T. (2022) · Research Square · doi:10.21203/rs.3.rs-2384009/v1
Rodrigues, B. D. S., Garmendia, X. C., Steemans, M., Gustin, E. M., Goethem, F. V., & Vinken, M. (2023) · Toxicology Letters · doi:10.1016/s0378-4274(23)00697-5
Rykalo, N. A., & Baylo, O. V. (2023) · Reports of Morphology · doi:10.31393/morphology-journal-2023-29(3)-04
Farzaneh, Z., Keivan, M., & Farzaneh, M. (2024) · Authorea · doi:10.22541/au.170664851.18059918/v1
High throughput production and characterization of primary rat hepatocyte spheroids
Gökaltun, A. (2024) · Hacettepe Journal of Biology and Chemistry · doi:10.15671/hjbc.1394326
Safety Pharmacology in the Era of Precision Medicine
Al-Mahayri, Z. N., & Nagy, M. (2024) · Springer eBooks · doi:10.1007/978-3-030-73317-9_89-1
Safety Pharmacology in the Era of Precision Medicine
Al-Mahayri, Z. N., & Nagy, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_89
Vos, K. D., Mols, R., Armoudjian, Y., Augustijns, P., & Annaert, P. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-03979-4
Jackson, J. P., & Brouwer, K. R. (2025) · Applied In Vitro Toxicology · doi:10.1177/23321539251399331
Additional file 1 of Cholangiocyte organoids to study drug-induced injury
Wang, Z., Xing, C., van der Laan, L. J. W., Verstegen, M. M. A., Spee, B., & Masereeuw, R. (2024) · Figshare · doi:10.6084/m9.figshare.25397460
Mise au point et développement de modèles hépatiques complexes par bio-impression 3D
Cuvellier, M. (2020) · theses.fr (ABES) · doi:10.70675/b6c577cdzcaffz460az8214z9681de8f3941
Messelmani, T. (2023) · theses.fr (ABES) · doi:10.70675/9a8f7a80zb4ebz4faczb395zff9d3d7ddeac
Luo, M., Wang, Q. X., Wang, Y., Li, F., Zhang, A., & Zhao, Y. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c01434
Szabó, E., Telbisz, Á., Erdei, Z., Farkas, K., Homolya, L., Sarkadi, B., & Apáti, Á. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100157 · Cited by 1
New approach methodologies for in vitro detection of chemical-induced cholestatic liver injury
Maerten, A., Avîrvarei, A.-C., & Vinken, M. (2026) · Archives of Toxicology · doi:10.1007/s00204-026-04541-6
Hattori, K., Naito, Y., Shinoda, T., Yamada, Y., Kitano, S., & Matsusaki, M. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.215250
Metadata
- Authors
- Hendriks, D. F. G., Fredriksson Puigvert, L., Messner, S., Mortiz, W., & Ingelman-Sundberg, M.
- Affiliations
- Karolinska Institutet (SE)
- Venue
- Scientific Reports
- Published
- 2016-10-19
- Volume
- 6
- Issue
- 1
- Pages
- 35434-35434
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5069690
- OpenAlex
- W2539243243
- Cited by
- 156
- References
- 51
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 10 · 2022: 17 · 2021: 18 · 2020: 26 · 2019: 23 · 2018: 18 · 2017: 10
- FWCI
- 21.37
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Commission (115336, 267038)
- Vetenskapsrådet (FP7/2007-2013)
- Staatssekretariat für Bildung, Forschung und Innovation
- Eurostars
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Keywords
- drug-induced cholestasis, primary human hepatocytes, HepaRG cells, bile salt export pump, bile acids, synergistic toxicity, chlorpromazine, hepatotoxicity, ABCB11, F-actin cytoskeleton, oxidative stress, death receptor signaling
- MeSH terms
- Bile Acids and Salts, Biological Transport, Cell Line, Chlorpromazine, Cholestasis, Humans, Signal Transduction, Oxidative Stress, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Receptors, TNF-Related Apoptosis-Inducing Ligand, Chemical and Drug Induced Liver Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.